Governance
ko en
Governance
IPK Executive Leadership Team
  • Chief Executive Officer (CEO)
    Byungkwon LIM, MA
    Biography
  • Chief Scientific Officer (CSO)
    Dimitri Lavillette, Ph.D
    Biography

  • Myung-Chul LEE

    Chairman

    Korean Academy of Science and Technology, Rep. of Korea

  • Hyuk-Chae KOO

    Ministry of Science and ICT, Rep. of Korea

  • JeKyung SEONG

    Seoul National University/Korea Mouse Phenotyping Center, Rep. of Korea

  • Isabelle BUCKLE

    Institut Pasteur, France

  • Kwang-Yeol RYU

    Gyeonggi Provincial Government, Rep.
    of Korea

  • Gwan Sun LEE

    Hanmi Pharmaceutical Co. Ltd, Rep. of Korea

  • Fernando ARENZANA-SEISDEDOS

    Institut Pasteur, France

  • Dimitri LAVILLETTE

    Institut Pasteur Korea, Rep. of Korea

  • Stewart COLE

    Institut Pasteur, France

  • Byungkwon LIM

    Institut Pasteur Korea, Rep. of Korea

  • Jinsun PARK

    Auditor

    Korea Nuclear International Cooperation Foundation, Rep. of Korea

  • Neil CARRAGHER

    Chair

    University of Edinburgh, United Kingdom

  • Ivo Gomperts BONECA

    Institut Pasteur, France

  • Joon Haeng RHEE

    Chonnam National University College of Medicine, Rep. of Korea

  • Koo LEE

    Therapex Corp., Rep. of Korea

  • Malik PEIRIS

    The University of Hong Kong, Hong Kong

  • Sang Hoon LEE

    ABL Bio, Inc., Rep. of Korea

  • Seonggu RO

    PiMedBio Inc., Rep. of Korea

  • Tae-Wook CHUN

    NIAID/NIH, USA

  • Yae-Jean KIM

    Samsung Medical Center, Rep. of Korea

Chief Executive Officer (CEO)

Youngmee JEE, MD, PhD
EDUCATION
  • 1989-1997

    PhD, Virology, University of London, UK

  • 1988

    Diploma, Medical Microbiology, University of London, UK

  • 1980-1986

    MD, Medicine, College of Medicine, Seoul National University, Rep. of Korea

Major Career
  • 2021-present

    Chief Executive Officer & Director, Institut Pasteur Korea, Rep. of Korea

  • 2014-2019

    Director-General, the Center for Infectious Disease Research and the Center for Immunology and Pathology,
    Korea National Institute of Health(KNIH), Korea Centers for Disease Control and Prevention(KCDC) (Currently, KDCA)

  • 2016-2019

    Member of Board of Trustee, International Vaccine Institute (IVI)

  • 2007-2014

    Scientist/Regional Coordinator, Expanded Programme on Immunization,
    World Health Organization (WHO) Western Pacific Regional Office

  • 1997-2007

    Deputy Director/Director, Division of Enteric and Hepatitis Viruses, Korea National Institute of Health, KCDC

Other Career & Experience
  • 2021

    President, The Korean Society for Microbiology

  • 2020-present

    Special Representative of Health and Diplomacy, the Korea Foundation

  • 2020-present

    Member of the WHO Emergency Committee on COVID-19

  • 2019-2020

    Visiting Professor, Graduate School of Public Administration, Seoul National University, Rep. of Korea

  • 2018-2019

    Member of Board of Director, RIGHT Fund

  • 2017-present

    Member of the Korea Expert Committee on Immunization Practices (KECIP)

  • 2017-2020

    Member of WHO Strategic Advisory Group of Experts on Immunization (SAGE)

  • 2017-2019

    President, Korean Society for Infectious Diseases (KSID)

  • 2015-present

    Member of the WHO R&D Blueprint Scientific Advisory Group

  • 2014-2019

    Head, Task Force Team for the Cross-ministerial Forum on Infectious Disease Research and Development (FID)

Chief Executive Officer (CEO)

Byungkwon Lim, MA
EDUCATION
  • 2005-2007

    MA, University of Salford, Manchester, UK

  • 1988-1991

    BSc, Seoul National University of Science and Technology, Rep. of Korea

Major Career
  • 2022-present

    CEO, Institut Pasteur Korea, Rep. of Korea

  • 2017-2022

    Admin Executive Director, Institut Pasteur Korea, Rep. of Korea

  • 2016-2017

    Head of Planning Division, International Science Business Belt Creation Promotion Team, Ministry of Science, ICT and Future Planning, Rep. of Korea

  • 2014-2016

    Head of User Protection Division, Seoul Radio Management Center, Ministry of Science, ICT and Future Planning, Rep. of Korea

  • 2012-2014

    Dispatched to IAEA (International Atomic Energy Agency)

  • 2011-2012

    Director of Exhibition Planning Division, National Science Museum, Rep. of Korea

  • 2008-2009

    Secretary of the Human Resources Policy Division and the International Cooperation Policy Division, Ministry of Education, Science and Technology, Rep. of Korea

  • 2007-2008

    Deputy Director of General Planning Division, Science and Technology Policy Bureau, Ministry of Science and Technology, Rep. of Korea

  • 1992-2005

    Deputy Director of the Planning and Management Office, the Science Policy Bureau and the R&D Bureau, Ministry of Science and Technology, Rep. of Korea

Chief Scientific Officer (CSO)

Dimitri Lavillette, Ph.D, Dr. Habil
EDUCATION
  • 2009

    Habilitation à diriger les recherches, ENS Lyon, France

  • 1997-2000

    PhD in Virology, Ecole Normale Supérieure, ENS Lyon, France

  • 1994-1997

    Master of Differentiation, Genetic and Immunology at the University Claude Bernard, Lyon, France

  • 1991-1994

    Bachelor of Science in Biochemistry, Dijon University, Dijon, France

Major Career
  • 2022-Present

    Chief Scientific Officer, Institut Pasteur Korea, Rep. of Korea

  • 2014-2022

    HeadProfessor, Principal Investigator, Pasteur Institute of Shanghai CAS

  • 2012-2014

    Associate Professor, Claude Bernard Lyon University – Microbial Ecology, Lyon

  • 2003-2012

    Associate Professor, Virology and Immunology Department, Ecole Normale Superieure ENS-Lyon